CIK: 0001388551
申报总市值
US$402.4万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | 股票-其他 | 41.06% | — | -60.59% | |
| 2 | RZLT | Rezolute INC | 股票-其他 | 38.85% | — | — | |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 9.94% | — | -1.53% | |
| 4 | BRK-B | Berkshire Hathaway Inc-cl B | 股票-其他 | 3.09% | +0.32% | -1.56% | |
| 5 | GLD | Spdr Gold Shares | ETF-避险与商品 | 1.70% | +17.00% | — | |
| 6 | BRD1EUR | Mind Medicine Mindmed INC | 股票-其他 | 1.43% | -4.91% | EXIT | |
| 7 | BCAX | Bicara Therapeutics INC | 股票-其他 | 1.15% | — | — | |
| 8 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 0.71% | -1.25% | — | |
| 9 | KYTX | Kyverna Therapeutics INC | 股票-其他 | 0.52% | -0.09% | — | |
| 10 | CMPX | Compass Therapeutics INC | 股票-其他 | 0.38% | -3.70% | EXIT | |
| 11 | CRDF | Cardiff Oncology INC | 股票-其他 | 0.35% | — | — | |
| 12 | IKT | Inhibikase Therapeutics INC | 股票-其他 | 0.32% | -0.17% | — | |
| 13 | GLYCEUR | Glycomimetics INC | 股票-其他 | 0.31% | — | — | |
| 14 | CNTX | Context Therapeutics INC | 股票-其他 | 0.12% | -0.63% | EXIT | |
| 15 | TORCEUR | Adicet Bio INC | 股票-其他 | 0.10% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | +12.4% | — | 不变 |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +3.1% | -1.53% | 减仓 |
| 3 | GLD | Spdr Gold Shares | +1.7% | NEW | 新建仓 |
| 4 | BRK-B | Berkshire Hathaway Inc-cl B | +0.9% | -1.56% | 减仓 |
| 5 | BRD1EUR | Mind Medicine Mindmed INC | +0.6% | — | 不变 |
| 6 | CRDF | Cardiff Oncology INC | +0.4% | NEW | 新建仓 |
| 7 | IKT | Inhibikase Therapeutics INC | +0.3% | NEW | 新建仓 |
| 8 | GLYCEUR | Glycomimetics INC | +0.3% | NEW | 新建仓 |
| 9 | KYTX | Kyverna Therapeutics INC | +0.1% | — | 不变 |
| 10 | CMPX | Compass Therapeutics INC | +0.1% | — | 不变 |
| 11 | LXEO | Lexeo Therapeutics INC | 0% | — | 不变 |
| 12 | BCAX | Bicara Therapeutics INC | — | — | 不变 |
| 13 | TORCEUR | Adicet Bio INC | — | — | 不变 |
| 14 | CNTX | Context Therapeutics INC | 0% | — | 不变 |
| 15 | ABVX | Abivax Sa-adr | -0.5% | EXIT | 清仓 |
| 16 | XERS | Xeris Biopharma Holdings INC | -19.3% | -60.59% | 减仓 |